Correlation
The correlation between GSK.L and JPM is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
GSK.L vs. JPM
Compare and contrast key facts about GlaxoSmithKline plc (GSK.L) and JPMorgan Chase & Co. (JPM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK.L or JPM.
Performance
GSK.L vs. JPM - Performance Comparison
Loading data...
Key characteristics
GSK.L:
-0.64
JPM:
1.26
GSK.L:
-0.72
JPM:
1.75
GSK.L:
0.90
JPM:
1.25
GSK.L:
-0.59
JPM:
1.38
GSK.L:
-0.98
JPM:
4.62
GSK.L:
16.47%
JPM:
7.30%
GSK.L:
25.40%
JPM:
28.39%
GSK.L:
-51.33%
JPM:
-74.02%
GSK.L:
-17.17%
JPM:
-6.30%
Fundamentals
GSK.L:
£57.84B
JPM:
$724.54B
GSK.L:
£0.76
JPM:
$20.38
GSK.L:
18.76
JPM:
12.79
GSK.L:
0.38
JPM:
7.10
GSK.L:
1.83
JPM:
4.29
GSK.L:
4.09
JPM:
2.19
GSK.L:
£31.53B
JPM:
$228.61B
GSK.L:
£22.58B
JPM:
$186.05B
GSK.L:
£8.24B
JPM:
$104.01B
Returns By Period
In the year-to-date period, GSK.L achieves a 8.33% return, which is significantly lower than JPM's 10.00% return. Over the past 10 years, GSK.L has underperformed JPM with an annualized return of 4.85%, while JPM has yielded a comparatively higher 17.97% annualized return.
GSK.L
8.33%
3.48%
8.70%
-16.09%
-3.62%
1.27%
4.85%
JPM
10.00%
6.57%
6.08%
32.91%
30.83%
27.34%
17.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK.L vs. JPM — Risk-Adjusted Performance Rank
GSK.L
JPM
GSK.L vs. JPM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK.L) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GSK.L vs. JPM - Dividend Comparison
GSK.L's dividend yield for the trailing twelve months is around 4.35%, more than JPM's 1.94% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK.L GlaxoSmithKline plc | 4.35% | 4.53% | 3.84% | 4.69% | 4.98% | 5.96% | 4.50% | 5.36% | 6.05% | 4.93% | 5.83% | 5.81% |
JPM JPMorgan Chase & Co. | 1.94% | 1.92% | 2.38% | 2.98% | 2.34% | 2.83% | 2.37% | 2.54% | 1.91% | 2.13% | 2.54% | 2.49% |
Drawdowns
GSK.L vs. JPM - Drawdown Comparison
The maximum GSK.L drawdown since its inception was -51.33%, smaller than the maximum JPM drawdown of -74.02%. Use the drawdown chart below to compare losses from any high point for GSK.L and JPM.
Loading data...
Volatility
GSK.L vs. JPM - Volatility Comparison
GlaxoSmithKline plc (GSK.L) has a higher volatility of 8.55% compared to JPMorgan Chase & Co. (JPM) at 4.95%. This indicates that GSK.L's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GSK.L vs. JPM - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GSK.L vs. JPM - Profitability Comparison
GSK.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported a gross profit of 5.58B and revenue of 7.52B. Therefore, the gross margin over that period was 74.2%.
JPM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, JPMorgan Chase & Co. reported a gross profit of 45.31B and revenue of 68.89B. Therefore, the gross margin over that period was 65.8%.
GSK.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported an operating income of 2.22B and revenue of 7.52B, resulting in an operating margin of 29.5%.
JPM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, JPMorgan Chase & Co. reported an operating income of 18.41B and revenue of 68.89B, resulting in an operating margin of 26.7%.
GSK.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, GlaxoSmithKline plc reported a net income of 1.62B and revenue of 7.52B, resulting in a net margin of 21.6%.
JPM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, JPMorgan Chase & Co. reported a net income of 14.64B and revenue of 68.89B, resulting in a net margin of 21.3%.